Memorial Sloan Kettering Cancer Center: Immunoblastic Lymphadenopathy trials
The registry lists 10 Immunoblastic Lymphadenopathy studies with Memorial Sloan Kettering Cancer Center as lead sponsor. 1 are open to participants now and 1 have results posted.
Phase 1 5Phase 2 3Phase 3 2No phase 1(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- A Registry for People With T-cell LymphomaRecruitingNCT05978141
- Clofarabine in Treating Patients With T-Cell or Natural Killer-Cell Non-Hodgkin's Lymphoma That Has Relapsed or Not Responded to Previous TreatmentCompletedNCT00416351Phase 1/2Results posted
- Pyroxamide in Treating Patients With Advanced CancerCompletedNCT00042900Phase 1
- ZD0473 and Doxorubicin in Treating Patients With Advanced Solid Tumors or LymphomaCompletedNCT00016172Phase 1
- Caspofungin Acetate Compared With Amphotericin B Liposomal in Treating Patients With Persistent Fever and Neutropenia Following Cancer TreatmentCompletedNCT00008359Phase 3
- St. John's Wort in Relieving Fatigue in Patients Undergoing Chemotherapy or Hormone Therapy for CancerCompletedNCT00005805Phase 3
- Arsenic Trioxide in Treating Patients With Relapsed or Refractory Non- Hodgkin's LymphomaCompletedNCT00005040Phase 2
- Paclitaxel Plus L-778,123 in Treating Patients With Recurrent or Refractory Solid Tumors or LymphomasCompletedNCT00004057Phase 1
- Combination Chemotherapy in Treating Patients With Advanced CancerCompletedNCT00003956Phase 1
- Combination Chemotherapy and Bone Marrow Transplantation in Treating Patients With Leukemia or Myelodysplastic SyndromeCompletedNCT00002502Phase 2